194
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prevalence of Trachoma in Four Evaluation Units in Yemen after Implementation of Trachoma Elimination Measures

, , , , , , , , , , , ORCID Icon & show all
Received 02 Jun 2022, Accepted 10 Feb 2023, Published online: 13 Mar 2023

Figures & data

Table 1. Population enumerated, examined, and reasons for nonparticipation during trachoma impact surveys in two governates of Yemen, October 2019.

Figure 1. Prevalence of trachomatous inflammation—follicular (TF) in 1−9-year-olds in trachoma impact surveys of four evaluation units of Yemen, October 2019. The prevalence of trachomatous trichiasis (TT) unknown to the health system in ≥15-year-olds was <0.2% in all EUs surveyed. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the authors, or the institutions with which they are affiliated, concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

Figure 1. Prevalence of trachomatous inflammation—follicular (TF) in 1−9-year-olds in trachoma impact surveys of four evaluation units of Yemen, October 2019. The prevalence of trachomatous trichiasis (TT) unknown to the health system in ≥15-year-olds was <0.2% in all EUs surveyed. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the authors, or the institutions with which they are affiliated, concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

Figure 2. Change in prevalence of trachomatous inflammation—follicular (TF) in 1−9-year-olds following one round of antibiotic mass drug administration. X-axis coordinates have been artificially adjusted to prevent overlap and allow confidence intervals to be seen more clearly. Pre-MDA prevalence estimates are taken from Thabit et al., 201814. Pre-MDA prevalence estimates in Al Hodeidah governate are from four districts surveyed as a single EU: Al Mighlaf, Al Munirah, As Salif and Az Zaydiyah. Prevalence estimates from Ibb governate are from three districts surveyed as a single EU, one of which was not re-surveyed in this series: Al Udayn (not resurveyed), Far Al Udayn and Mudhaykhirah. Because the pre-MDA and post-MDA EU boundaries are not identical, potential changes in prevalence between time points are not interpretable.

Figure 2. Change in prevalence of trachomatous inflammation—follicular (TF) in 1−9-year-olds following one round of antibiotic mass drug administration. X-axis coordinates have been artificially adjusted to prevent overlap and allow confidence intervals to be seen more clearly. Pre-MDA prevalence estimates are taken from Thabit et al., 201814. Pre-MDA prevalence estimates in Al Hodeidah governate are from four districts surveyed as a single EU: Al Mighlaf, Al Munirah, As Salif and Az Zaydiyah. Prevalence estimates from Ibb governate are from three districts surveyed as a single EU, one of which was not re-surveyed in this series: Al Udayn (not resurveyed), Far Al Udayn and Mudhaykhirah. Because the pre-MDA and post-MDA EU boundaries are not identical, potential changes in prevalence between time points are not interpretable.

Table 2. Prevalence of trachomatous inflammation—follicular (TF) in children aged 1−9 years in trachoma impact surveys of two governates of Yemen, October 2019.

Table 3. Prevalence of trachomatous trichiasis (TT) in people aged ≥15 years in trachoma impact surveys, two governates of Yemen, October 2019.

Table 4. Household water, sanitation and hygiene access, trachoma impact surveys, two governates of Yemen, October 2019.

Supplemental material

Supplemental Material

Download MS Word (16.2 KB)